NCT00224263 Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00217321 Parkinson's Disease Registry of the Muhammad Ali Parkinson Center Status UNKNOWN Phase N/A
NCT00212693 Controlled Study of ONO-2506PO in Patients With Parkinson's Disease in Japan Status COMPLETED Phase PHASE2
NCT00209508 2 Year Study to Evaluate the Effects of GPI 1485 on [123I]b-CIT/SPECTScanning and Clinical Efficacy in Patients With PD Status COMPLETED Phase PHASE2
NCT00208611 Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease Status TERMINATED Phase PHASE2/PHASE3
NCT00203957 Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa Status COMPLETED Phase PHASE3
NCT00203177 Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy. Status COMPLETED Phase PHASE3
NCT00203164 Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients Status COMPLETED Phase PHASE3
NCT00203138 Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease Status COMPLETED Phase PHASE3
NCT00203125 A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study. Status COMPLETED Phase PHASE3
NCT00203060 Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa Status COMPLETED Phase PHASE3
NCT00203034 Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations Status COMPLETED Phase PHASE3
NCT00203008 A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma Status COMPLETED Phase N/A
NCT00202657 Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide Status COMPLETED Phase N/A
NCT00200447 An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN) Status COMPLETED Phase PHASE2
NCT00199433 A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients Status COMPLETED Phase PHASE2
NCT00199420 A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa Status COMPLETED Phase PHASE3
NCT00199407 A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa Status COMPLETED Phase PHASE3